524
Participants
Start Date
March 1, 2022
Primary Completion Date
December 31, 2025
Study Completion Date
March 31, 2026
clozapine
Biotype 1 and Biotype 2
risperidone
Biotype 1 and Biotype 2
RECRUITING
University of Georgia, Athens
RECRUITING
University of Chicago, Chicago
RECRUITING
UT Southwestern Medical Center, Dallas
RECRUITING
Hartford Healthcare, Hartford
RECRUITING
Beth Israel Deaconess Medical Center, Boston
National Institute of Mental Health (NIMH)
NIH
Beth Israel Deaconess Medical Center
OTHER
Hartford Hospital
OTHER
University of Georgia
OTHER
University of Chicago
OTHER
University of Texas Southwestern Medical Center
OTHER